MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Valion Bio, Inc. (VBIO)

Valion Bio, Inc. (VBIO)

|||

Balance Sheets Overview

Current Ratio
111.03%
Quick Ratio
86.41%
Cash Ratio
69.21%
Debt to Asset Ratio
63.40%
Unit: Thousand (K) dollars
Assets Breakdown
    • Property and equipment, gross
    • Right-of-use assets, operating l...
    • Goodwill
    • Others
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others
Balance Sheets
2026-06-30
2026-03-31
Cash and cash equivalents
2,108
7,215
Prepaid expenses and other current assets
524
687
Inventory, net
750
750
Current assets of discontinued operations
0
0
Total current assets
3,382
8,652
Property and equipment, gross
12,720
12,664
Less accumulated depreciation
377
20
Property and equipment, net
12,343
12,644
Deferred offering costs
631
555
Licensed technology, net
2,243
2,243
Right-of-use assets, operating lease
9,835
10,086
Goodwill
3,457
3,457
Restricted cash
368
368
Other assets
214
210
Total assets
32,473
38,215
Accounts payable
639
629
Accrued expenses
1,831
1,490
Operating lease liabilities, current
533
492
Current liabilities of discontinued operations
43
4
Total current liabilities
3,046
2,615
Convertible note payable, net
7,388
6,899
Derivative liability
212
259
Operating lease liabilities, non-current
9,488
9,643
Other non-current liabilities
454
251
Total liabilities
20,588
19,667
Temporary equity-Series BPreferred Stock
1,421
1,420
Temporary equity-Series CPreferred Stock
6,218
6,066
Common stock, 0.0001 par value, 200,000,000 shares authorized 4,151,919 and 2,525,778 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
2
2
Additional paid in capital
70,750
70,094
Accumulated deficit
-66,506
-59,034
Total stockholders equity
4,246
11,062
Total liabilities, temporary equity and stockholders' equity
32,473
38,215
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property and equipment,gross$12,720K Cash and cashequivalents$2,108K Inventory, net$750K Prepaid expenses andother current assets$524K Property and equipment,net$12,343K Right-of-use assets,operating lease$9,835K Goodwill$3,457K Total current assets$3,382K Licensed technology, net$2,243K Deferred offering costs$631K Restricted cash$368K Other assets$214K Less accumulateddepreciation$377K Total assets$32,473K Total liabilities,temporary equity and...$32,473K Total liabilities$20,588K Temporary equity-SeriesCPreferred Stock$6,218K Total stockholdersequity$4,246K Temporary equity-SeriesBPreferred Stock$1,421K Accumulated deficit-$66,506K Operating leaseliabilities, non-current$9,488K Convertible note payable,net$7,388K Total currentliabilities$3,046K Other non-currentliabilities$454K Derivative liability$212K Additional paid in capital$70,750K Common stock, 0.0001par value,...$2K Accrued expenses$1,831K Accounts payable$639K Operating leaseliabilities, current$533K Current liabilities ofdiscontinued operations$43K